ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025

Pharmacogenetic testing to broaden patient eligibility for mavacamten.

Lorenz Van der Linden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.